This fact warrants the addition of TANK to the SYSCID map and suggests that the combination of downregulated TANK and TBK1 and IRF3 hypo-phosphorylation could be a potential mechanistic molecular biomarker for remission in IBD patients. Here, IRF3 is linked to inflammatory bowel disease.